The protective effect of EGb 761 in isolated ischemic/reperfused rat hearts: A link between cardiac function and nitric oxide production

Journal of Cardiovascular Pharmacology

Volumn 34, Issue 5, 1999, Pages 711-717

  Varga, Edit ^a   Bodi, Annamaria ^a   Ferdinandy, Peter ^b   Droy Lefaix, Marie Therese ^c   Blasig, Ingolf E ^d   Tosaki, Arpad ^a,e  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c IPSEN   (France)

^d LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

^e UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Cardiac function; iNOS mRNA; Ischemia; Nitric oxide; Rat heart; Reperfusion

Indexed keywords

GINKGO BILOBA EXTRACT; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL TISSUE; AORTA FLOW; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOSE RESPONSE; DRUG EFFECT; HEART FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ISOLATED HEART; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRON SPIN RESONANCE SPECTROSCOPY; FLAVONOIDS; FREE RADICAL SCAVENGERS; GINKGO BILOBA; HEART FUNCTION TESTS; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; MYOCARDIAL REPERFUSION INJURY; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PLANT EXTRACTS; PLANTS, MEDICINAL; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0032744519     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199911000-00013     Document Type: Article

References (30)

1. Kobuchi H, Droy-Lefaix MT, Christen Y, Packer L. Ginkgo biloba extract (EGb 761): inhibitory effect on nitric oxide production in the macrophage cell line RAW 264.7. Biochem Pharmacol 1997; 53:897-903.
2. Luss H, Li RK, Shapiro RA, et al. Dedifferentiated human ventricular cardiac myocytes express inducible nitric oxide synthase mRNA but not protein in response to IL-1, TNF, IFNτ, and LPS. J Mol Cell Cardiol 1997;29:1153-65.
3. Dawson V, Dawson T, Bartley D, Uhl G, Snyder SH. Mechanisms od nitric oxide mediated neurotoxicity in primary brain cultures. J Neurosci 1993;13:2651-61.
4. Matheis G, Sherman MP, Buckberg GD, Haybron DM, Young HH, Ignarro LJ. Role of L-arginine-nitric oxide pathway in myocardial reoxygenation injury. Am J Physiol 1992;262:H616-20.
5. Habib FM, Springall DR, Davies GJ, Oakley CM, Yacoub MH, Polak JM. Tumor necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet 1996;347:1151-5.
6. Recchia FA, McConnell PI, Bernstein RD, Vogel TR, Xu X, Hintze TH. Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. Circ Res 1998;83:969-79.
7. DeFeudis FV. Ginkgo biloba extract (EGb 761): from chemistry to the clinic. In: DeFeudis FV, ed. Ginko biloba extract (EGb 761). Wiesbaden: Ullstein Medical, 1998:1-15.
8. Marcocci L, Maguire JJ, Droy-Lefaix MT, Packer L. Peroxyl radical scavenging activity of Ginkgo biloba extract EGb 761. Biochem Biophys Res Commun 1994;201:748-55.
9. Tosaki A, Hellegouarch A. Adenosine triphosphate-sensitive potassium channel blocking agent ameliorates, but the opening agent aggravates, ischemia/reperfusion-induced injury: heart function studies in nonfibrillating isolated hearts. J Am Coll Cardiol 1994; 23:487-96.
10. Mulsch A, Mordvintcev P, Vanin A. Quantification of nitric oxide in biological samples by electron spin resonance spectroscopy. Neuroprotection 1992;1:165-73.
11. Ferdinandy P, Appelbaum J, Csonka C, Blasig IE, Tosaki A. Role of nitric oxide and TPEN, a potent metal chelator, in ischemic and reperfused isolated rat hearts. Clin Exp Pharmacol Physiol 1998; 25:496-502.
12. Csont T, Pali T, Szilvassy Z, Ferdinandy P. Lack of correlation between myocardial nitric oxide and cyclic guanosine monophosphate content in both nitrate-tolerant and nontolerant rats. Biochem Pharmacol 1998;56:1139-44.
13. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
14. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res 1980;47:1-9.
15. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43:109-42.
16. Liu P, Hock CE, Nagele R, Wong PY. Formation of nitric oxide, superoxide, and peroxynitrate in myocardial ischemia/reperfusion injury in rats. Am J Physiol 1997;272:H2327-36.
17. Fukuchi M, Hussain SN, Giaid A. Heterogeneous expression and activity of endothelial and inducible nitric oxide synthases in end-stage human heart failure: their relation to lesion cite and beta-adrenergic receptor therapy. Circulation 1998;98:132-9.
18. Vejlstrup NG, Bouloumie A, Boesgaard S, et al. Inducible nitric oxide synthase (iNOS) in the human heart: expression and localization in congestive heart failure. J Mol Cell Cardiol 1998;30: 1215-23.
19. Wildhirt SM, Suzuki H, Horstman D, et al. Selective modulation of inducible nitric oxide synthase isoenzyme in myocardial infarction. Circulation 1997;96:1616-23.
20. Pinsky DJ, Oz MC, Koga S, et al. Cardiac preservation is enhanced in a heterotopic rat transplant model by supplementing the nitric oxide pathway. J Clin Invest 1994;93:2291-7.
21. Morita K, Sherman MP, Buckberg GD, et al. Studies of hypoxemic/reoxygenation injury: without aortic clamping: V. Role of the L-arginine-nitric oxide pathway: the nitric oxide paradox. J Thorac Cardiovasc Surg 1995;110:1200-11.
22. Woolfson RG, Patel VC, Neild GH, Yellon DM. Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism. Circulation 1995;91:1545-51.
23. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implication for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 1990;87:1620-4.
24. Geng Y, Hansson GK, Holme E. Interferon-τ and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells. Circ Res 1992;71:1268-76.
25. Kostic MM, Schrader J. Role of nitric oxide in reactive hyperemia of the guinea pig heart. Circ Res 1992;70:208-12.
26. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-12.
27. Pinsky DJ, Cai B, Yang X, Rodriguez C, Sciacca RR, Cannon PJ. The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor β. J Clin Invest 1995;95:677-85.
28. Kantengwa S, Polla BS. Flavonoids, but not protein kinase C inhibitors, prevent stress protein synthesis during erythrophagocytosis. Biochem Biophys Res Commun 1991;180:308-14.
29. Hortelano S, Genaro AM, Bosca L. Phorbol esters induce nitric oxide synthase activity in rat hepatocytes: antagonism with the induction elicited by lipopolysaccharide. J Biol Chem 1992;267: 24937-40.
30. Tosaki A, Maulik N, Engelman DT, Engelman RM, Das DK. The role of protein kinase C in ischemic/reperfused preconditioned isolated rat hearts. J Cardiovasc Pharmacol 1996;28:723-31.